A decade ago, when China had not fully engaged in multi-center clinical trials, DIA came to China to host its first annual meeting in Beijing with the theme of “Drug Development in A Flat World:Innovation, Regulation and Globalization”. Since its inception in 2009, DIA China has committed to becoming a neutral forum in catalyzing knowledge creation and sharing to accelerate health product development in China. In the past two years, China Food and Drug Administration (CFDA) had demonstrated unprecedented resolve and determination of regulatory reform which had reached to the milestone of becoming regulatory member of ICH in June 2017. 

Do you want to be part of DIA Asia's largest interdisciplinary event in 2018? Do you want to contribute to the extraordinary event in the most encouraging era of life science innovation in China?  
Call for Topics
Call for Topics is now starting!  Join us and propose topics or sessions in 2018 the 10th DIA China Meeting:

·         Regulatory Science
·         Clinical Development
·         Quantitative Science
·         Medical Affairs
·         Therapeutic hot topics 
·         Generic Drugs
·         Pharmacovigilance 
·         Big Data Research and Artificial Intelligence in Healthcare 
·         Patient Engagement 
·         Translational Medicine
·         Hot Topics & Late Breaker

Topic submissions will be reviewed by the Annual Meeting Program Committee to assist with the content development and strategy for DIA China 2018. Submission of a topic is not in any way related to a speaking role at DIA China 2018. A Call for Abstracts will be available in the fall of 2017 to solicit sessions and presentations for DIA China 2018.
Topic submission deadline: August 31, 2017